Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide + Topotecan in Refractory/Relapsed Neuroblastoma and Paediatric Solid Tumours
NCT00918320Phase 2Completed
- Sponsor
- Gustave Roussy
- Start
- Jun 2009
- Primary completion
- Oct 2013
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide, topotecan liposome in neuroblastoma, brain tumor, solid tumor, sponsored by Gustave Roussy. Started Jun 2009; status: completed.
02
Drugs
temozolomidetopotecan liposome
03
Conditions
neuroblastomabrain tumorsolid tumor
Beyond the preview
Go deeper on NCT00918320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00918320.